ALIRA SPRING: Open Payments
NPI 1538584958 · MISSOULA, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$659 in 32 payments from 8 companies in 2025. Trend: 2023 $304 · 2024 $275 · 2025 $659
Food & beverage: $559Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $252 |
| Janssen Biotech, Inc. | 7 | $191 |
| UCB, Inc. | 3 | $60 |
| LEO Pharma Inc. | 3 | $56 |
| Amgen Inc. | 3 | $48 |
| Incyte Corporation | 2 | $36 |
| Organon LLC | 1 | $9 |
| BioWound Solutions, Inc. | 1 | $8 |
Products named: TREMFYA, BOTOX, SKYRIZI, Bimzelx, RINVOQ, OTEZLA, ADBRY, OPZELURA.
Industry payments across MT — which companies pay providers there.
